glp-1 dangers Medications: Is Ozempic the Best Option for You? GLP-1 Side Effects: A Complete

On January 2024, Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical business, has launched a biosimilar of the popular10,11 anti-diabetic medication Liraglutide for the first time in India

For suspected inflammatory conditions, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) may be appropriate

Diabetologia 60(8):13851389

Meanwhile, participants with chronic obstructive sleep apnea slept better after treatment

Does Wegovy increase the risk of glaucoma or macular degeneration

Additionally, the core and consistent assembly technology that spans from the companys smaller benchtop assembly unit to its higher commercial assembly platform facilitates efficient industrialisation scale-up, which is advantageous for existing and new entrants in the GLP-1 space